Kuros biosciences: completion of the acquisition of checkmate pharmaceuticals by regeneron pharmaceuticals triggers a $5 million milestone payment

Ad-hoc announcement pursuant to article 53 of the six listing rules
REGN Ratings Summary
REGN Quant Ranking